发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| Japan | 69 |
| CHINA MAINLAND | 24 |
| Taiwan | 19 |
| South Korea | 18 |
| USA | 17 |
| Italy | 15 |
| GERMANY (FED REP GER) | 13 |
| France | 8 |
| England | 5 |
| Austria | 4 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| KINDAI UNIVERSITY (KINKI UNIVERSITY) | 34 |
| NATIONAL TAIWAN UNIVERSITY | 12 |
| OGAKI MUNICIPAL HOSPITAL | 9 |
| SEOUL NATIONAL UNIVERSITY (SNU) | 8 |
| TAIPEI VETERANS GENERAL HOSPITAL | 8 |
| UNIVERSITY OF ULSAN | 8 |
| EHIME PREFECTURAL CENT HOSP | 7 |
| NATIONAL YANG MING CHIAO TUNG UNIVERSIT... | 7 |
| UNIVERSITY OF TOKYO | 7 |
| ZHEJIANG UNIVERSITY | 7 |
文章引用情况
1
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma2
Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial3
Liver Stiffness Measured by Two-Dimensional Shear-Wave Elastography: Prognostic Value after Radiofrequency Ablation for Hepatocellular Carcinoma4
NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization5
Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals6
Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma Treatment7
Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study8
9th Asia-Pacific Primary Liver Cancer Expert Meeting, Seoul, South Korea, July 6- 2018 Abstracts9
Irradiation-Related Lymphopenia for Bone Metastasis from Hepatocellular Carcinoma10
The 10th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2019), Sapporo, Japan, August 29- 2019 Abstracts